Apollo Hospitals Enterprise, a prominent player in the hospital industry, currently holds a market capitalisation of ₹1,05,567.41 crore, categorising it firmly within the large-cap segment. The company’s price-to-earnings (P/E) ratio stands at 63.51, slightly below the hospital sector’s average P/E of 64.26, indicating valuation levels that are broadly in line with industry peers. This valuation context is crucial for investors analysing the stock’s relative attractiveness within the healthcare domain.
On 19 November 2025, Apollo Hospitals Enterprise was officially designated as a constituent of the Nifty 50 index, following an adjustment in its evaluation that reflects its market prominence and liquidity. The Nifty 50 index, being a benchmark for the Indian equity market, carries significant weight in portfolio construction for institutional investors and index funds. Inclusion in this index often leads to increased demand from passive funds and can influence trading volumes and price dynamics.
Examining the stock’s recent price movements, Apollo Hospitals Enterprise opened at ₹7,400 on the day of analysis and traded consistently at this level. The stock’s day change registered a decline of 0.57%, which was more pronounced than the Sensex’s marginal fall of 0.15%. This performance aligns with the sector’s trend, as the stock’s movement was inline with hospital industry peers on the same day.
From a technical perspective, the stock price remains above its 200-day moving average, signalling a long-term support level. However, it is trading below its 5-day, 20-day, 50-day, and 100-day moving averages, suggesting short- to medium-term pressures. This mixed technical picture may reflect market participants’ cautious stance amid broader sectoral and macroeconomic factors.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- Long-term growth stock
- Multi-quarter performance
- Sustainable gains ahead
Looking at Apollo Hospitals Enterprise’s performance over various time horizons provides further insight into its market trajectory. Over the past year, the stock recorded a gain of 9.66%, marginally outperforming the Sensex’s 8.98% rise. However, shorter-term returns have been less favourable. The one-week performance shows a decline of 2.13%, contrasting with the Sensex’s slight increase of 0.09%. Similarly, the one-month and three-month periods reveal declines of 7.17% and 6.05% respectively for Apollo Hospitals Enterprise, while the Sensex posted gains of 0.71% and 3.55% over the same intervals.
Year-to-date, the stock’s performance is modest at 0.63%, lagging behind the Sensex’s 8.20% advance. Despite these recent fluctuations, Apollo Hospitals Enterprise’s longer-term returns remain robust. Over three years, the stock has appreciated by 66.94%, significantly outpacing the Sensex’s 37.11% gain. The five-year and ten-year performances are even more pronounced, with returns of 219.44% and 457.25% respectively, compared to the Sensex’s 93.91% and 227.17% over the same periods. These figures highlight the company’s sustained growth trajectory and its ability to generate value over extended durations.
Institutional holdings in Apollo Hospitals Enterprise are a critical factor influencing its market dynamics, especially following its Nifty 50 inclusion. Adjustments in institutional portfolios often accompany index changes, as mutual funds, insurance companies, and foreign portfolio investors recalibrate their holdings to align with benchmark compositions. While specific changes in institutional shareholding percentages are not disclosed here, the stock’s large-cap status and index membership typically attract increased institutional interest, which can impact liquidity and price stability.
The hospital sector itself is undergoing transformation, driven by rising healthcare demand, technological advancements, and evolving regulatory frameworks. Apollo Hospitals Enterprise, as a sector leader, is positioned to benefit from these trends, although it faces challenges such as cost pressures and competitive intensity. Its valuation relative to the sector average suggests that the market is factoring in both growth prospects and sector-specific risks.
Want to dive deeper on Apollo Hospitals Enterprise .? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- Real-time research report
- Complete fundamental analysis
- Peer comparison included
In summary, Apollo Hospitals Enterprise’s inclusion in the Nifty 50 index underscores its significance within the Indian equity market and the hospital sector. While recent short-term price movements have shown some softness relative to the broader market, the company’s long-term performance metrics remain compelling. Investors should consider the implications of index membership, institutional holding adjustments, and sectoral factors when analysing the stock’s prospects.
As the healthcare landscape evolves, Apollo Hospitals Enterprise’s market capitalisation, valuation metrics, and benchmark status will continue to play pivotal roles in shaping its investment profile. Monitoring these elements alongside broader market trends will be essential for stakeholders seeking to understand the stock’s position within India’s dynamic equity environment.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
